Harnessing the Plasma Proteome to Mirror Current and Predict Future Cardiac Remodeling After Myocardial Infarction

[1]  F. Bengel,et al.  Characterizing the transition from immune response to tissue repair after myocardial infarction by multiparametric imaging , 2022, Basic Research in Cardiology.

[2]  M. Lindsey,et al.  Macrophages secrete murinoglobulin-1 and galectin-3 to regulate neutrophil degranulation after myocardial infarction , 2022, Molecular omics.

[3]  Michael E. Hall,et al.  Faster skin wound healing predicts survival after myocardial infarction , 2022, American journal of physiology. Heart and circulatory physiology.

[4]  M. Lindsey,et al.  S100A9 is a functional effector of infarct wall thinning after myocardial infarction , 2021, American journal of physiology. Heart and circulatory physiology.

[5]  M. Lindsey,et al.  Neutrophil crosstalk during cardiac wound healing after myocardial infarction. , 2021, Current opinion in physiology.

[6]  P. Pagliaro,et al.  Regulation of STAT3 and its role in cardioprotection by conditioning: focus on non-genomic roles targeting mitochondrial function , 2021, Basic Research in Cardiology.

[7]  Min Zhang,et al.  Regulatory B cells improve ventricular remodeling after myocardial infarction by modulating monocyte migration , 2021, Basic Research in Cardiology.

[8]  M. Lindsey,et al.  Reperfused vs. Non-reperfused Myocardial Infarction: When to Use Which Model. , 2021, American journal of physiology. Heart and circulatory physiology.

[9]  F. Montecucco,et al.  Cytokines as therapeutic targets for cardio- and cerebrovascular diseases , 2021, Basic Research in Cardiology.

[10]  M. Lindsey,et al.  Infarct in the Heart: What’s MMP-9 Got to Do with It? , 2021, Biomolecules.

[11]  Kathleen M. Jagodnik,et al.  Gene Set Knowledge Discovery with Enrichr , 2021, Current protocols.

[12]  K. Peter,et al.  Alarmin-activated B cells accelerate murine atherosclerosis after myocardial infarction via plasma cell-immunoglobulin-dependent mechanisms. , 2020, European heart journal.

[13]  M. Lindsey,et al.  Neutrophil signaling during myocardial infarction wound repair. , 2020, Cellular signalling.

[14]  M. Lindsey,et al.  Exogenous IL-4 shuts off pro-inflammation in neutrophils while stimulating anti-inflammation in macrophages to induce neutrophil phagocytosis following myocardial infarction , 2020, Journal of molecular and cellular cardiology.

[15]  M. Lindsey,et al.  Cardiac Fibroblast Activation during Myocardial Infarction Wound Healing: Fibroblast polarization after MI. , 2020, Matrix biology : journal of the International Society for Matrix Biology.

[16]  O. Akgul,et al.  The prognostic value of elevated matrix metalloproteinase-9 in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A two-year prospective study , 2020, Revista Portuguesa de Cardiologia (English Edition).

[17]  M. Lindsey,et al.  The compendium of matrix metalloproteinase expression in the left ventricle of mice following myocardial infarction. , 2020, American journal of physiology. Heart and circulatory physiology.

[18]  Jianfang Liu,et al.  The expression of interleukin-25 increases in human coronary artery disease and is associated with the severity of coronary stenosis , 2020, Anatolian journal of cardiology.

[19]  Anindita Das,et al.  STAT3-miR-17/20 Signaling Axis Plays a Critical Role in Attenuating Myocardial Infarction following Rapamycin Treatment in Diabetic mice. , 2019, Cardiovascular research.

[20]  M. Lindsey,et al.  Understanding the mechanisms that determine extracellular matrix remodeling in the infarcted myocardium. , 2019, Biochemical Society transactions.

[21]  M. Lindsey,et al.  Neutrophil proteome shifts over the myocardial infarction time continuum , 2019, Basic Research in Cardiology.

[22]  M. Carli,et al.  Cardiovascular Volume Reserve in Patients with Heart Failure and Reduced Ejection Fraction , 2019, Journal of Cardiovascular Translational Research.

[23]  Michael E. Hall,et al.  Identifying the molecular and cellular signature of cardiac dilation following myocardial infarction. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[24]  S. Feinstein,et al.  Reciprocal Multifaceted Interaction Between HDL (High-Density Lipoprotein) and Myocardial Infarction. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[25]  Pei Yang,et al.  E3-ubiquitin ligase TRIM6 aggravates myocardial ischemia/reperfusion injury via promoting STAT1-dependent cardiomyocyte apoptosis , 2019, Aging.

[26]  M. Lindsey,et al.  Fibroblast polarization over the myocardial infarction time continuum shifts roles from inflammation to angiogenesis , 2019, Basic Research in Cardiology.

[27]  Liu Liu,et al.  HDAC inhibitor valproic acid protects heart function through Foxm1 pathway after acute myocardial infarction , 2018, EBioMedicine.

[28]  K. Fukuda,et al.  IL (Interleukin)-10–STAT3–Galectin-3 Axis Is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction , 2018, Circulation.

[29]  Abdullah Kaplan,et al.  The Mouse Heart Attack Research Tool 1.0 database. , 2018, American journal of physiology. Heart and circulatory physiology.

[30]  Michael E. Hall,et al.  Exogenous CXCL4 infusion inhibits macrophage phagocytosis by limiting CD36 signalling to enhance post-myocardial infarction cardiac dilation and mortality , 2018, Cardiovascular research.

[31]  M. Lindsey,et al.  Statistical considerations in reporting cardiovascular research. , 2018, American journal of physiology. Heart and circulatory physiology.

[32]  A. Mebazaa,et al.  Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production , 2018, Theranostics.

[33]  M. Lindsey,et al.  Mapping macrophage polarization over the myocardial infarction time continuum , 2018, Basic Research in Cardiology.

[34]  Hailing Yang,et al.  Identification of Potential Molecular Mechanisms and Candidate Genes Involved in The Acute Phase of Myocardial Infarction , 2018, Cell journal.

[35]  Steven P Jones,et al.  Guidelines for experimental models of myocardial ischemia and infarction , 2018, American journal of physiology. Heart and circulatory physiology.

[36]  M. Lindsey,et al.  Guidelines for authors and reviewers on antibody use in physiology studies , 2018, American journal of physiology. Heart and circulatory physiology.

[37]  M. Lindsey,et al.  Guidelines for measuring cardiac physiology in mice , 2018, American journal of physiology. Heart and circulatory physiology.

[38]  M. Brizzi,et al.  Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects , 2017, Front. Physiol..

[39]  S. Halvorsen,et al.  MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy , 2017, Cardiology.

[40]  Xuemei Du,et al.  IL-25 blockade inhibits metastasis in breast cancer , 2016, Protein & Cell.

[41]  S. Prabhu,et al.  The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. , 2016, Circulation research.

[42]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[43]  A. R. van der Velde,et al.  Galectin-3 and post-myocardial infarction cardiac remodeling. , 2015, European journal of pharmacology.

[44]  D. Tsiantoulas,et al.  Targeting B cells in atherosclerosis: closing the gap from bench to bedside. , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[45]  H. Björkbacka,et al.  IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice , 2015, PloS one.

[46]  W. Abraham,et al.  Novel Non-pharmacological Approaches to Heart Failure , 2014, Journal of Cardiovascular Translational Research.

[47]  D. Tsiantoulas,et al.  B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction , 2013, Nature Medicine.

[48]  M. Lindsey,et al.  Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation. , 2013, Pharmacology & therapeutics.

[49]  D. Mann,et al.  Positioning of Inflammatory Biomarkers in the Heart Failure Landscape , 2013, Journal of Cardiovascular Translational Research.

[50]  T. Costantino,et al.  Neutrophil to lymphocyte ratio and cardiovascular diseases: a review , 2013, Expert review of cardiovascular therapy.

[51]  Y. Arbel,et al.  Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. , 2012, Atherosclerosis.

[52]  Dinender K Singla,et al.  Overexpression of TIMP-1 in Embryonic Stem Cells Attenuates Adverse Cardiac Remodeling following Myocardial Infarction , 2012, Cell transplantation.

[53]  R. Knight,et al.  STAT1 deficiency in the heart protects against myocardial infarction by enhancing autophagy , 2012, Journal of cellular and molecular medicine.

[54]  P. Armstrong,et al.  Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction , 2012, Coronary artery disease.

[55]  T. Kalin,et al.  Expression of Foxm1 Transcription Factor in Cardiomyocytes Is Required for Myocardial Development , 2011, PloS one.

[56]  R. Vasan,et al.  Biomarkers of Extracellular Matrix Metabolism (MMP-9 and TIMP-1) and Risk of Stroke, Myocardial Infarction, and Cause-Specific Mortality: Cohort Study , 2011, PloS one.

[57]  C. Corrigan,et al.  T-helper cell type 2 (Th2) memory T cell-potentiating cytokine IL-25 has the potential to promote angiogenesis in asthma , 2011, Proceedings of the National Academy of Sciences.

[58]  P. Schwarz,et al.  The iron-regulatory peptide hepcidin is upregulated in the ischemic and in the remote myocardium after myocardial infarction , 2010, Peptides.

[59]  J. Gardner,et al.  Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[60]  L. Ng,et al.  Biomarkers in acute myocardial infarction , 2010, BMC medicine.

[61]  J. V. van Engelshoven,et al.  Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach , 2010, International journal of vascular medicine.

[62]  John S. Hill,et al.  Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. , 2010, Journal of the American College of Cardiology.

[63]  Adelaide M. Arruda-Olson,et al.  Neutrophilia Predicts Death and Heart Failure After Myocardial Infarction: A Community-Based Study , 2009, Circulation. Cardiovascular quality and outcomes.

[64]  P. Scheffer,et al.  Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification? , 2009, Clinical chemistry.

[65]  Raj Kishore,et al.  IL-10 Inhibits Inflammation and Attenuates Left Ventricular Remodeling After Myocardial Infarction via Activation of STAT3 and Suppression of HuR , 2009, Circulation research.

[66]  I. Holme,et al.  Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS) , 2009, Annals of medicine.

[67]  N. Samani,et al.  Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction. , 2008, European heart journal.

[68]  V. Cameron,et al.  Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. , 2007, Journal of the American College of Cardiology.

[69]  Leong L Ng,et al.  Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study. , 2007, European heart journal.

[70]  A. Larsson,et al.  Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[71]  Peipei Ping,et al.  Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. , 2006, Journal of the American College of Cardiology.

[72]  S. Hazen,et al.  Abstract 601: Haptoglobin Genotype Determines Myocardial Infarct Size in Diabetic Mice , 2006 .

[73]  V. Chopra,et al.  Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction. , 2006, American heart journal.

[74]  I. Holme,et al.  High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study , 2001, The Lancet.

[75]  T. Iwasaka,et al.  Evidence for infection with Helicobacter pylori in patients with acute myocardial infarction. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[76]  M. Steffen,et al.  Systemic acute‐phase reactants, C‐reactive protein and haptoglobin, in adult periodontitis , 1997, Clinical and experimental immunology.

[77]  Andrew N. Rowan.  Guide for the Care and Use of Laboratory Animals , 1996 .

[78]  S. Tyagi,et al.  Serum haptoglobin in cases of ischemic heart diseases. , 1980, Japanese heart journal.

[79]  C. Binder,et al.  ATVB IN FOCUS: Clinically Available Immunotherapies: Expected Impact on Cardiovascular Disease , 2019 .

[80]  M. Borggrefe,et al.  High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction , 2007, Clinical chemistry and laboratory medicine.

[81]  P. Puddu,et al.  Increased serum IgA levels in subjects with previous myocardial infarction or other major ischemic events. , 1993, Cardiology.